
Opinion|Podcasts|February 5, 2025
Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves tebipenem pivoxil for complicated urinary tract infections
2
Behind the FDA approval of capivasertib for mHSPC, with Daniel J. George, MD
3
The ArteraAI Prostate Test: What It Is and How It Works
4
FDA gives nod to feasibility study of NanoKnife IRE for benign prostatic hyperplasia
5

















